Chapter 42 The safe management of medicines for children
INTRODUCTION
The Crown Report provides a comprehensive review of all aspects of drug administration that includes prescribing, supplying and administering medicines, and clearly states that: ‘No health professional should undertake any aspect of patient care for which they are not trained and which is beyond their professional competence’ (DoH 1999, p 23). Therefore, for students undertaking programmes to become registered children’s nurses, recognition of personal limits, knowledge, understanding and skills are an essential part of the learning process. This is also endorsed within the Nursing and Midwifery Council (NMC) Standards for Medicine Management (NMC 2008a).
RATIONALE
The administration of medicines to infants, children and teenagers requires a complex set of skills that must be grounded in a sound understanding of child development, not only in terms of biophysiological changes but also changes that occur from a psychological perspective (Watt 2003a). Knowledge and skills that are essential for children’s nurses include understanding the relevant underpinning theory to support care, being numerically competent and being an effective communicator (Nicol & Thompson 2000, 2001, NMC 2008a). For this to be realised, registered nurses must have a sound knowledge base regarding the administration of medicines, that draws upon the currently available literature and use this to inform everyday practice.
FACTORS TO NOTE
The main pieces of legislation that influence the administration of medicines within the UK: the Medicines Act (1968) and the Misuse of Drugs Act (1971) and the EU Regulation of Paediatric Medicine (2006), which came into effect in January 2007. Within the European Union there are approximately 75 million children between the ages of 0 and 16 years, which represents approximately one-fifth of the total population (European Commission 2002). Choonara (2000, 2008) acknowledges that children have the right to receive medicines that are not only safe but effective for use specifically with this client group. Saint-Raymond and Seigneuret (2005) and Choonara and Bonati (2007) highlight the fact that European legislation encourages the pharmaceutical industry to provide an evidence base for the use of medications for children (Choonara & Bonati 2007). The EU legislation ‘Better medicines for children’ should also provide sufficient incentive for pharmaceutical companies to develop medicines for children (Wong et al 2006).
The majority of the world’s children do not live in the UK or the USA where legislation supports and encourages the improvement of drug interventions; therefore the world’s most vulnerable children are arguably still at risk. According to Choonara (2008), the majority of the world’s children do not live where they have easy access to child appropriate medicines; within the UK in 2002, it was estimated that 200 million prescriptions for children and adolescents were issued (Costello et al 2004). In spite of these statistics, approximately 50–90% of all medicines administered to children have never been evaluated for use with children (Schaad 2001, European Commission 2002). This has had the effect of children becoming ‘therapeutic orphans’, which has led to the death of some children (Sutcliffe 2003). As a consequence, the European Commission proposed regulation of orphan medicinal products and this was adopted in December 1999 (European Commission 2002).
Within the UK, marketing authorisation is required from the Medicines Control Agency before medicines can be marketed and promoted (Wong et al 2006); however, it is common practice to prescribe unlicenced medicines (UL), also known as off label medicines (OL), to children; it is not illegal for a doctor to prescribe a medicine with different indicators or to children of different ages (McLay et al 2006, Stephenson 2000, 2001). Prescribing medicines that are off label is necessary when there is no suitable alternative (Watt 2003a). However, this practice of using ‘off label medicines’ is being associated with increased adverse reactions and has also been known to have fatal consequences particularly in neonatal care (Choonara & Conroy 2002). Of all admissions of children to hospital, at least one-third of the child population and 90% of infants in neonatal intensive care units, receive UL or OL drugs (Conroy et al 2000, Stephenson 2001); in primary care approximately 11–33% of prescriptions for children are UL or OL (McIntyre et al 2000). Medicines for Children (RCPCH 2003) is a relatively new formulary that provides practitioners with consensus views on correct dosages for children of all ages and is an important point of reference for all those involved in prescribing medicines to children. Please also note that the British National Formulary for children is an important reference point to use.
With reference to the administration of medicines, there are two key principles of common law, the first of which is the person’s right to self-determination. Griffith et al (2003) cite Lord Goff in Airdale NHS Trust v Bland [1993] and maintain that self-determination requires healthcare professionals to respect the wishes of patients and carers. The second principle involves the practitioner’s responsibility when administering medicines in any environment. A medicine that does have a product licence would be deemed to be unlicensed if, for example, tablets are crushed or capsules are opened, in which case the practitioner must be able to justify the reasons why this was done and may find themselves personally liable if harm comes to those receiving the medicine (Griffith et al 2003).
What is a medicine?
A medicinal product may be defined as any substance or combination of substances presented for treating or preventing disease in human beings or animals (Article 1.2 EC Directive 65/65 cited by the Crown Report, DoH 1999, p 79).
Within the Medicines Act (1968, section 130), there are three legal categories in which medicines can be grouped: according to potency, potential adverse effects and the need for the supply of some medicines to be professionally supervised (Crown Report, DoH 1999).
GUIDELINES FOR ADMINISTERING MEDICINES TO CHILDREN
The National Service Framework for Children (DoH 2003) clearly states that the administration of medicines to children must be based on the best available evidence to underpin practice. The NMC Standards for Medicine Management (NMC 2008a) clearly indicate that it is not a rule book to be adhered to, covering all potential situations that may be encountered in practice; instead it is a set of guiding principles that must be used in conjunction with local trust/hospital policy (DoH 2003), thereby attempting to reduce the potential for errors in the administration of medicines (Watt 2003b). Standard 18 of the NMC (2008a) Standards for Medicine Management clearly states: Students must never administer/supply medicinal products without direct supervision.
The Standards for Medicine Management (NMC 2008a) must be used in conjunction with local trust/hospital policies on how to administer and who can administer medicines, as policies and protocols will vary to meet local needs. The NMC (2008a) requires that the registered nurse or midwife be able to administer medicines in a way that is technically safe and that they should also be able to contribute to any decisions regarding the prescription in a clinically competent and professional manner. Nurses are accountable for the drugs that they administer; therefore a prerequisite must be knowledge about drug actions, side-effects and dosages of any drugs that are administered to the child (Standard 8 of the Standards for Medicine Management, NMC 2008a). Kaushal et al (2001) suggest that Adverse Drug Events (ADEs) in children may be more common than had been originally thought; Ghaleb et al (2005) suggest that this is because what constitutes ‘administering children’s medications’ is difficult to define.
Watt (2003b) identified the five ‘Cs’ as important principles to ensure the safe administration of medicines to all children:
To administer medication safely, the nurse must ensure that:
Record-keeping
Good record-keeping should be regarded as an important part of the process of administering medicines (NMC 2007b; see also local trust/hospital policies). It is the duty of the nurse administering the medicine to ensure that a record is made of the dose administered, the time given, the drug given and the administration route (Dimond 2003c). In the event of an error in medication administration being noted, it is important to follow trust policies for such an event; this usually includes ensuring the child is safe, informing the ward manager, doctor, parent and child. If appropriate, an incident form must be completed and the error documented in the patient’s notes (Watt 2003b). Dimond (2003c) acknowledges that there is a danger that if a mistake is made by a nurse, they will not acknowledge that it has happened for fear of reprisals. In the event that an error in administration of a medicine occurs, the NMC’s position is very clear in terms of advice to practitioners: What is important to recognise is that in the event that you do make an error in medicine administration, you must report it immediately to your line manager or employer (NMC 2008a). For individuals to admit when mistakes have been made, employers need to facilitate an open culture and one in which individuals are not fearful of reprisals. The NMC (2008b) is supportive of critical incident panels as a forum in which lessons can be learnt and improvements made to local practice, in light of such incidents (Dimond 2003c). As Dimond (2003c, p 761) highlights:
Storage of medicines
The manufacturers of medicines will usually indicate the type of storage conditions required, for example avoid sunlight or store at low temperatures, to ensure that drugs do not lose therapeutic effectiveness. There are legal obligations that each trust or care setting must adhere to as in cases where the manufacturer of a medicine is not known then the last person in the supply chain will be deemed to be the manufacturer and can be held liable for any damages against the person (Griffith et al 2003). It is essential that all trusts/hospitals/care settings where medicines are administered keep accurate details of all supplies of medicines and ensure that they are securely stored (Griffith et al 2003).
The storage of all medicines is subject to legal requirements and statutory instruments (Dimond 2003a) and to local trust/hospital policies; therefore all practitioners working within a trust are responsible for familiarising themselves with those policies. These will include the following guiding principles, as adapted from Griffith et al (2003):
Self-administration of medicines
The NHS Plan (DoH 2000) has, as a central theme, the importance of empowering patients to take an active role in their own care. The Audit Commission (2001) clearly indicates that patients are given the opportunity to learn about and take responsibility for their own medicines. Self-administration of medicines is not a new concept within the realms of adult care (DoH 2000), with many parts of the UK fully embracing this as everyday practice. However, self-administration in children’s nursing is a less established practice. Wright et al (2002) maintain that the role of the nurse in terms of administering medicines to children is not that of a ‘traditional role of administering’; adversely, it is now becoming a role that involves children and families managing their own medicines, with nurses focusing on education and facilitation of the child and family.
Nurse prescribing
To date, doctors, dentists and certain nurses are legally authorised to prescribe medicines. The Crown Report (DoH 1999) recommended the further development of the prescribing role and The NHS Plan (DoH 2000) highlighted that the prescribing of medicines and treatments is a key role for nurses. The Crown Report (DoH 1999) also identified that there needs to be training for the preparation of specific practitioners and needs to include Children’s Nurses (Dimond 2003d, Hutchinson & Hall 2003, NMC 2006, Pontin & Jones 2007).
Gibson et al (2003) have been able to demonstrate how nurse prescribing can be seen as a means of improving care delivery to children and families, and the expansion of the role of the clinical nurse specialist (CNS) as a ‘logical development’ in the expanding role of nurses. While it is anticipated that nurses are the most likely group of healthcare professionals to develop prescribing skills, it is also important to note that other health professionals such as physiotherapists may be accommodated within the legislation in the future (Dimond 2003d).
Developmental issues for consideration
There is a growing body of evidence that explores children’s knowledge and attitudes towards medication (Hämeen-Anttila et al 2006). Hämeen et al (2006) found that children’s understanding of medicines and related topics increased and became more complex with chronological development; therefore when children are being given medications, it is important that they are offered an explanation/education that not only reflects chronological development but also takes into account cognitive development (Hämeen-Anttila et al 2006). Preparation of children for any procedure is vital; this includes the giving of medicines and remembering to assess the child’s understanding (Hämeen-Anttila et al 2006). By communicating effectively and getting to know the children and families that you are involved in caring for will begin to gain their trust, understanding and cooperation, not only when administering medicines but in all other aspects of care.
Routes of administration
The administration of medicines to children is frequently an aspect of nursing care that causes concern for the child, family and nurse. Medicines may vary in form and are given by a range of routes (see Table 42.1). The child’s dignity, individuality and understanding need to be paramount when giving medicines (NMC 2008a, Standard 8), and whenever possible the family needs to be fully involved to reduce any trauma experienced by the child (Duff 2003). Additional consideration needs to be paid by the children’s nurse to the individual child’s cognitive development, communication and understanding throughout the whole procedure.
Route | Form |
---|---|
Gastric tube (via naso/oropharyngeal/direct) | Solutions, suspensions, syrups, elixirs, emulsions, oils |
Inhaled (into the lung) | Compressed air nebulisers, metered dose inhalers, powder devices, sterile liquids |
Injected: | |
Subcutaneous (under the skin) | Dependent on route: aqueous solutions, suspensions, lipid (fat) solutions, dilutions |
Intramuscular (into the muscle) | |
Intravenous (into the vein) | |
Intrathecal (into the cerebrospinal fluid) | |
Intraosseous (into the bone) | |
Arterially (into the artery) | |
Intra-aural (into the ear) | Solutions, suspensions, drops |
Intraocular (into the eye) | Solutions, suspensions, drops, ointments |
Intravaginal (into the vagina) | Pessaries, liquids, solutions, ointments, creams, lotions |
Nasally (into the nose) | Solutions, suspensions, drops, ointments, sprays |
Orally (by mouth) | Liquid: solutions, suspensions, syrups, elixirs, emulsions, oils Solid: tablets, capsules, granules, lozenges, beads |
Rectally (into the rectum) | Enemas, aqueous solutions, suspensions, oils, suppositories, ointments |
Sublingual (beneath the tongue) | Capsules, beads, granules, tablets, drops |
Topically (onto the skin) | Solutions, suspensions, ointments, sprays, creams, lotions, pastes, powders, shampoos, soaps, liquids |
Adapted from Royal College of Paediatrics and Child Health 1999.
Principles of medicine administration
For all routes, the following key aspects of technique/method apply:
ORAL MEDICATION
TECHNIQUE
Young infants
The young infant is likely to have a strong attachment to a parent and may become anxious with a ‘stranger’. The nurse’s role is to encourage parental involvement, provide positive reinforcement and promote sensory soothing measures (i.e. cuddling and stroking the infant) throughout the procedure (Watt 2003b).
Toddlers
As a toddler, the child is considered to be developing autonomy and striving for independence (Watt 2003b). Characteristically, the toddler will need clear instructions and a firm direct approach. The toddler is likely to have a strong bond with their parents but may be interested in exploring new tastes and sensations; therefore, whenever possible, allow the child to participate and take the medication independently. Promote the full involvement of the parents and the use of positive reinforcement, encouragement and praise. Toddlers can be encouraged through play and fun; however, medications should not be disguised in a drink, such as a milk shake, as the full volume may not be taken and the child may feel betrayed if they discover the deception, and refuse to drink at all.
NASOGASTRIC, OROGASTRIC OR GASTROSTOMY MEDICATION
Medication administration via the nasogastric, orogastric or gastrostomy route is directly into the stomach via a tube (see Ch. 40). For the child who has an indwelling tube placed directly into the stomach, medications may be prescribed via this route instead of orally. However, there are a number of precautions associated with this route.
GUIDELINES AND PRECAUTIONS
(See also Westhus 2004, Wyllie 2004, Beckstrand et al 2007, Clarke & Richardson 2007a,b.)
INTRAVENOUS MEDICATION
While there is a requirement that prior to registration a student nurse will have been involved in the monitoring and assessment of children receiving intravenous fluids (NMC 2007a), the administration of intravenous medication is a role that requires the completion and assessment competence after registration in line with local trust policy. Intravenous (i.v.) medication (administered directly into the vein) may be given by intermittent bolus injection, continuous or intermittent infusion, or via peripheral or central access devices (see Chs 34 and 41). The choice of technique will depend on the pharmacological characteristics of the medication (half-life, preferred plasma levels) and the lifestyle of the child (e.g. intermittent bolus injections may be preferable to continuous infusion in children who are at school).
Intravenous medication has the following benefits:
However, intravenous medication also carries with it the following potential complications: